60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.500
0.00 (0.00%)
At close: May 13, 2026, 4:00 PM EDT
1.517
+0.017 (1.16%)
After-hours: May 13, 2026, 7:39 PM EDT
60 Degrees Pharmaceuticals Employees
60 Degrees Pharmaceuticals had 3 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$469,698
Profits / Employee
-$2,622,071
Market Cap
3.96M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3 | 0 | - |
| Dec 31, 2024 | 3 | 0 | - |
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| GeoVax Labs | 19 |
| Virax Biolabs Group | 19 |
| VivoSim Labs | 14 |
| Azitra | 13 |
| Revelation Biosciences | 9 |
| Alzamend Neuro | 6 |
| Galmed Pharmaceuticals | 6 |
| Indaptus Therapeutics | 5 |
SXTP News
- 27 days ago - 60 Degrees Pharmaceuticals Transcript: Biotech Resurgence: Platforms and Pipelines of Today's Innovators - Transcripts
- 4 weeks ago - 60 Degrees Pharmaceuticals reports Arakoda availability on Runway Health website - TheFly
- 6 weeks ago - 60 Degrees Pharmaceuticals Announces 2025 Annual Results - GlobeNewsWire
- 2 months ago - 60 Degrees submits NDIN to FDA for Australian Chestnut Extract - TheFly
- 2 months ago - 60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract - GlobeNewsWire
- 2 months ago - 60 Degrees reports all patients cured of babesiosis after tafenoquine treatment - TheFly
- 2 months ago - 60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial - GlobeNewsWire
- 3 months ago - 60 Degrees expands access to Arakoda with GoodRx partnership - TheFly